269 related articles for article (PubMed ID: 26825212)
1. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of adrenal carcinoma.
Gaujoux S; Weinandt M; Bonnet S; Reslinger V; Bertherat J; Dousset B
J Visc Surg; 2017 Oct; 154(5):335-343. PubMed ID: 28754418
[TBL] [Abstract][Full Text] [Related]
3. [¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
Kreissl MC; Schirbel A; Fassnacht M; Haenscheid H; Verburg FA; Bock S; Saeger W; Knoedler P; Reiners C; Buck AK; Allolio B; Hahner S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2755-64. PubMed ID: 23609836
[TBL] [Abstract][Full Text] [Related]
4. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
5. American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach.
Kiseljak-Vassiliades K; Bancos I; Hamrahian A; Habra M; Vaidya A; Levine AC; Else T
Endocr Pract; 2020 Nov; 26(11):1366-1383. PubMed ID: 33875173
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
7. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical carcinoma: the range of appearances on CT and MRI.
Bharwani N; Rockall AG; Sahdev A; Gueorguiev M; Drake W; Grossman AB; Reznek RH
AJR Am J Roentgenol; 2011 Jun; 196(6):W706-14. PubMed ID: 21606258
[TBL] [Abstract][Full Text] [Related]
9. Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients.
Takeuchi S; Balachandran A; Habra MA; Phan AT; Bassett RL; Macapinlac HA; Chuang HH
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2066-73. PubMed ID: 24990404
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
[TBL] [Abstract][Full Text] [Related]
11. Metomidate-based imaging of adrenal masses.
Hahner S; Sundin A
Horm Cancer; 2011 Dec; 2(6):348-53. PubMed ID: 22124841
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET in adrenocortical carcinoma.
Becherer A; Vierhapper H; Pötzi C; Karanikas G; Kurtaran A; Schmaljohann J; Staudenherz A; Dudczak R; Kletter K
Cancer Biother Radiopharm; 2001 Aug; 16(4):289-95. PubMed ID: 11602999
[TBL] [Abstract][Full Text] [Related]
13. Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management.
Ahmed AA; Thomas AJ; Ganeshan DM; Blair KJ; Lall C; Lee JT; Morshid AI; Habra MA; Elsayes KM
Abdom Radiol (NY); 2020 Apr; 45(4):945-963. PubMed ID: 31894378
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-DOTAGA-IAC PET/CT for Imaging Metastatic and Recurrent Adrenocortical Carcinoma: A Case Series.
Pandey S; Walia R; Kumar R; Chopra S; Rana N; Chatterjee D; Satz S; Mittal BR; Shukla J
Clin Nucl Med; 2023 Feb; 48(2):e95-e98. PubMed ID: 36607383
[TBL] [Abstract][Full Text] [Related]
15. Characterization of adrenocortical tumors by
Paladino NC; Guérin C; Lowery A; Attard A; Essamet W; Slotema E; Morange I; Castinetti F; Brue T; Loundou A; Taïeb D; Sebag F
Surg Oncol; 2018 Jun; 27(2):231-235. PubMed ID: 29937176
[TBL] [Abstract][Full Text] [Related]
16. Recurrent adrenocortical carcinoma after laparoscopic resection.
Schlamp A; Hallfeldt K; Mueller-Lisse U; Pfluger T; Reincke M
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):191-5; quiz 1 p following 195. PubMed ID: 17237845
[TBL] [Abstract][Full Text] [Related]
17. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
18. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Gust L; Taieb D; Beliard A; Barlier A; Morange I; de Micco C; Henry JF; Sebag F
World J Surg; 2012 Jun; 36(6):1406-10. PubMed ID: 22131094
[TBL] [Abstract][Full Text] [Related]
19. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
[TBL] [Abstract][Full Text] [Related]
20. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]